Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ascendis Pharma

Founders Jan Mu00f8ller Mikkelsen

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$95M
Portfolio companies 1
Rounds per year 0.13
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.50
Key employees Soon

Areas of investment

  • Life Science
  • Biotechnology
  • Pharmaceutical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ascendis Pharma:
Typical Co-investors
Ascendis Pharma is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ascendis Pharma:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Abstraction Capital Kansas City, Missouri, United States
Adapt Low Carbon Group Norfolk, Norwich, United Kingdom
Ambina Partners Connecticut, Greenwich, United States
Amigo Health Grapeview, United States, Washington
aMoon2 Fund -
BACS-Innov -
CMG-SDIC Capital Management Beijing, Beijing, China
DoubleRock California, Menlo Park, United States
ES Investor Seoul, Seoul-t'ukpyolsi, South Korea
IDFC-Parampara Fund India, Maharashtra, Mumbai
Maxula Seed Fund Gabès, Tunis, Tunisia
NFX Ventures -
NXChain Inc California, Tustin, United States
Peak Ventures Lehi, United States, Utah
Revera Home Health Business -
Roclink Capital Canada, Ontario, Toronto
S-Equity Partner -
SIAR Capital New York, New York, United States
Sony Electronics California, San Diego, United States
Venture Frogs California, San Francisco, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Visen Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$150M08 Jan 2021 Shanghai, China

Visen Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$40M13 Nov 2018 Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ascendis Pharma?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 95M
Rounds per year 0.13
Peak activity year 2018
Lead investments 1
Follow on index 0.50
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Visen Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$150M08 Jan 2021 Shanghai, China

Visen Pharmaceuticals

Biotechnology
Life Science
Pharmaceutical
$40M13 Nov 2018 Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: